Showing 1,121 - 1,140 results of 2,897 for search '"Stem cell"', query time: 0.08s Refine Results
  1. 1121
  2. 1122
  3. 1123

    All-Trans Retinoic Acid Inhibits Bone Marrow Mesenchymal Stem Cell Commitment to Adipocytes via Upregulating FRA1 Signaling by Linjun Xie, Liying Zou, Jie Chen, Youxue Liu

    Published 2020-01-01
    “…Bone marrow mesenchymal stem cells (BMSCs) can differentiate into adipocytes. …”
    Get full text
    Article
  4. 1124
  5. 1125
  6. 1126
  7. 1127
  8. 1128
  9. 1129
  10. 1130
  11. 1131

    Bone Marrow Mesenchymal Stem Cells Enhance the Differentiation of Human Switched Memory B Lymphocytes into Plasma Cells in Serum-Free Medium by Guillaume Bonnaure, Catherine Gervais-St-Amour, Sonia Néron

    Published 2016-01-01
    “…We tested low oxygen concentrations and coculture with mesenchymal stem cells (MSC) from human bone marrow. Besides, all cultures were performed using an animal protein-free medium. …”
    Get full text
    Article
  12. 1132
  13. 1133

    Skeletal muscle stem cells modulate niche function in Duchenne muscular dystrophy mouse through YY1-CCL5 axis by Yang Li, Chuhan Li, Qiang Sun, Xingyuan Liu, Fengyuan Chen, Yeelo Cheung, Yu Zhao, Ting Xie, Bénédicte Chazaud, Hao Sun, Huating Wang

    Published 2025-02-01
    “…Abstract Adult skeletal muscle stem cells (MuSCs) are indispensable for muscle regeneration and tightly regulated by macrophages (MPs) and fibro-adipogenic progenitors (FAPs) in their niche. …”
    Get full text
    Article
  14. 1134
  15. 1135
  16. 1136
  17. 1137

    Hypoxia Promotes Glioma Stem Cell Proliferation by Enhancing the 14-3-3β Expression via the PI3K Pathway by Weidong Cao, Qiang Zhou, Hongwei Wang, Wei Rao, Gang Cheng, Peng Wang, Shengli Guo, Bin Ren, Jianning Zhang

    Published 2022-01-01
    “…The overall 5-year survival rate remains low due to high recurrence rates. Glioma stem cells (GSCs) play the important roles in the development of gliomas. …”
    Get full text
    Article
  18. 1138

    IMPACT-CABG Trial: Implantation of CD133+ Stem Cells in Patients Undergoing Coronary Bypass Surgery—Presentation of the First Treated Patient by Jessica Forcillo, Louis-Mathieu Stevens, Samer Mansour, Ignacio Prieto, Denis-Claude Roy, Nicolas Noiseux

    Published 2011-01-01
    “…The IMPACT-CABG study is the first Canadian randomized-controlled phase II clinical trial aiming to assess the effect of intramyocardial (IM) injections of CD133+-selected stem cells in patients referred for coronary artery bypass graft (CABG) with a “chronic” myocardial infarction and persistent left ventricular dysfunction. …”
    Get full text
    Article
  19. 1139
  20. 1140